Arterial blood pressure (BP) increases with
|
|
- Jean Kelly
- 6 years ago
- Views:
Transcription
1 AJH 1998;11: ORIGINAL CONTRIBUTIONS Estradiol-17 Reduces Blood Pressure and Restores the Normal Amplitude of the Circadian Blood Pressure Rhythm in Postmenopausal Hypertension Giuseppe Mercuro, Sandra Zoncu, Davide Piano, Isa Pilia, Adriana Lao, Gian Benedetto Melis, and Angelo Cherchi After menopause, both systolic (SBP) and diastolic (DBP) blood pressure (BP) become higher in women than in men of the same age, suggesting that estrogen deficiency may influence the agerelated increase in BP. We studied 30 postmenopausal women (mean age, years; time from menopause, 2 5 years) affected by mild hypertension with no target-organ complications by means of 24-h BP monitoring. None of the group were undergoing estrogen replacement therapy or taking antihypertensive drugs. According to a randomized, double-blind protocol, subjects received patches of transdermal estradiol- 17 (E 2 ) or a matched placebo, with crossover after a 7-day washout period. In 12 patients the 24-h peak-to-trough variation in SBP and DBP amounted to less than 10% (nondippers). Administration of E 2 significantly decreased 24-h SBP and DBP in the whole cohort (P <.05). Furthermore, E 2 restored the expected reduction in BP during nighttime in the nondipper subgroup. It is well known that estrogen replacement therapy protects against the development of both cardiovascular diseases and stroke. Our data suggest that this activity could be attributed, at least in part, to the activity of E 2 in preserving physiologic circadian fluctuation of BP. Am J Hypertens 1998;11: American Journal of Hypertension, Ltd. KEY WORDS: Menopause, ambulatory blood pressure monitoring, essential hypertension, diurnal ABP profile, hormone replacement therapy. Received August 13, Accepted March 9, From the Institute of Cardiology and Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Sardinia, Italy. Address correspondence and reprint requests to Prof. Giuseppe Mercuro, MD, Institute of Cardiology, University of Cagliari, Via S. Giorgio, 12, Cagliari, Sardinia, Italy. Arterial blood pressure (BP) increases with age and women manifest a higher BP after the age of 60 years. 1 5 This rise is more accelerated in postmenopausal than in premenopausal women. 2 After menopause, the agerelated increase may cause BP to exceed normal limits 6 ; accordingly, hypertension is prevalent among postmenopausal women compared to age-matched male subjects. 7 The finding that surgically induced menopause, irrespective of subjects age, is associated with an accelerated increase of arterial BP 8,9 appears to indicate a direct involvement of estrogen insufficiency with the rapid increase in arterial BP after menopause. On the other hand, a significant association between the reduction of the magnitude of the BP nighttime dip and future cardiovascular events has been demonstrated in women with essential hypertension. 10 We previously stated that the administration of estradiol- 17 (E 2 ) exerts beneficial effects, both in lowering el by the American Journal of Hypertension, Ltd /98/$19.00 Published by Elsevier Science, Inc. PII S (98)00096-X
2 910 MERCURO ET AL AJH AUGUST 1998 VOL. 11, NO. 8, PART 1 evated blood pressure levels and in maintaining a uniform blood pressure control over 24 h in postmenopausal women with hypertension occurring subsequent to cessation of ovarian function. 11 In the present study we examined the effect of acute administration of physiologic doses of E 2 on BP in a group of postmenopausal hypertensive women by means of ambulatory BP monitoring (ABPM). In particular, we studied the 24-h BP profile in the nondipper subgroup, whose nighttime ambulatory BP fell by less than 10%, with respect to daytime BP. MATERIALS AND METHODS Patients Thirty postmenopausal women (mean [ SD] age, years, range, years) with menopause occuring over the previous 2 to 5 years were studied. The postmenopausal status was clearly confirmed by an estradiol blood concentration 25 pg/ml, accompanied by a follicle-stimulating hormone (FSH) concentration of 20 IU/mL. Patients were affected by mild to moderate essential hypertension, 12 the onset of which had occurred 1 to 3 years earlier. All were free from target-organ complications. No subjects were receiving hormone replacement therapy. All antihypertensive drugs were withdrawn at least five drug half-lives before the study. Elevated BP values were confirmed after the washout period by a 24-h ABPM. No participant was characterized by further specific risk factors for cardiovascular disease, such as high total cholesterol and LDL, diabetes, obesity, or habitual smoking. Screening ABPM Before Study Protocol The present study was approved by the Ethical Committee of our university. Informed consent was obtained from all women. All subjects were weighed and measured. According to ABPM profiles, subjects were divided into two groups according to the presence (dippers) or absence (nondippers) of a nocturnal SBP and DBP decline greater than 10% of daytime values. At baseline, the comparison between dipper (n 18, 60%) and nondipper (n 12, 40%) hypertensive women showed no differences in age, time from menopause, body mass index, mean plasma levels of estradiol and FSH, office BP, heart rate, and routine laboratory tests (Table 1). Study Protocol According to a randomized, doubleblind, crossover protocol, nine dipper and six nondipper subjects applied patches of transdermal estradiol- 17 for a period of approximately 36 hours. Patches were rated to deliver 100 mg/day of E 2 (Estraderm TTS 100; Ciba-Geigy, Origgio, VA Italy). Subsequently, placebo patches were applied for an equivalent period of time; the remaining participants in the study received the drugs in the reverse order. The two experimental sessions were separated by a 1-week TABLE 1. DESCRIPTION OF DIPPER AND NONDIPPER HYPERTENSIVE WOMEN Dippers (n 18) Nondippers (n 12) Age (years) Time from menopause (years) BMI (kg/m 2 ) Estradiol-17 (pg/ml) FSH (IU/mL) Office blood pressure SBP (mm Hg) DBP (mm Hg) Pulse rate (beats/min) Serum glucose (mg/dl) Serum creatinine (mg/dl) Plasma total cholesterol (mg/dl) Plasma HDL (mg/dl) Plasma triglycerides (mg/dl) BMI, body mass index; FSH, follicle-stimulating hormone; SBP, systolic blood pressure; DBP, diastolic blood pressure. Values are means SD. washout period. In the 2 days immediately before each experimental session all subjects were required to abstain from smoking, drinking alcohol and coffee, and from undertaking severe physical exercise. The women wore the skin patches at home beginning at 11:00 pm. The following day subjects came to our laboratory from 8:00 to 9:00 am and underwent 24-h ABPM (ABP Monitor SpaceLabs Medical, Inc., Redmond, WA) at our clinic. The technique of ABPM was based on recommendations that emerged at the Fourth International Conference on ABPM in Leuven, Belgium, During the daytime, subjects were free to ambulate inside the hospital premises. Reclining and napping were not allowed. Identical standard varied meals were served to women during both experimental sessions. All women were required to retire to bed by 10:00 pm and to remain recumbent until 6:00 am the next morning. The sampling interval was 15 min between 6:00 am and 10:00 pm (daytime period) and 30 min between 10:00 pm and 6:00 am (nighttime period). Circulating E 2 levels were determined by radioimmunoassay. 14 Data Analysis The mean percentage of readings of ambulatory recordings excluded from analysis was 12 5% per ambulatory recording. All group data are reported as means SD. We tested the normal distribution of 24-h BP values for individual records by the Shapiro-Wilk test. The Student s t test for paired data was used when both records of the same subject were normally distributed. The Wilcoxon s signed-rank test was used if data were not normally distributed. All calculated P values were considered as significant when.05.
3 AJH AUGUST 1998 VOL. 11, NO. 8, PART 1 HYPERTENSION, MENOPAUSE, AND TRANSDERMAL ESTROGEN 911 RESULTS Characteristics of the Patients No patient showed left ventricular hypertrophy. Nevertheless, the nondipper subgroup was characterized by a nonsignificant higher myocardial mass. Mean plasma concentration of estradiol after placebo was pg/ml, subsequent to transdermal E 2 ; it was pg/ml (P.01). No E 2 -treated woman reported any adverse symptoms. Ambulatory Blood Pressure Monitoring Figure 1 shows a plot of hourly means for SBP, DBP, and pulse rate over a 24-h period in nondipper hypertensive women after placebo and E 2. The nocturnal reductions of SBP and DBP in the dippers were 8.4% and 13%, respectively, v 3.4% and 5.3% in nondippers (Table 2). Nighttime SBP and DBP measurements resulted in statistically lower values in the group of dipper hypertensives. Estradiol-17 treatment was associated with a reduction in both SBP and DBP values throughout the majority of the 24-h period when assessed by ABPM, both in dipper and nondipper subjects (Table 2). Compared with placebo, E 2 reduced daytime SBP and DBP and nighttime SBP in the dipper subgroup (Table 2), whereas in the nondippers only nighttime SBP and DBP were significantly lower after hormone treatment. Average 24-h and daytime pulse rates were reduced by E 2 only in dippers (P.05). In comparison with placebo, E 2 administration did not produce a significant difference in the dippers nocturnal fall of SBP ( 13 mm Hg v 11 mm Hg) and DBP ( 11 mm Hg v 12 mm Hg). On the other hand, we observed a greater fall in nighttime DBP in nondippers after E 2 ( 10 mm Hg, 10.8%) than after placebo ( 5mmHg, 5.2%; P.05), although nighttime SBP did not differ significantly after the two treatments ( 7mmHgv 5 mm Hg). Thus, E 2 removed the previously observed difference between nighttime DBP values in the dipper and nondipper subgroups. DISCUSSION Women are at higher risk of cardiovascular diseases after menopause. 15,16 The most important change observed in risk factors linked to the menopause is represented by an alteration in the serum lipid and lipoprotein concentrations. 17 However, other factors, such as an age-related rise in arterial BP, should also be considered. 1 Women are characterized by a lower systolic BP than men younger than the age of 40, whereas after middle age both systolic and diastolic BP become higher in women than in men. 1 5 It is still not clear whether or not ovarian insufficiency contributes to this rapid increase. However, it has been observed that in both natural and surgically induced menopause with oophorectomy this accelerated rise is further increased 16,18 and may produce abnormally FIGURE 1. Line graphs show hourly means for systolic blood pressure (top panel), diastolic blood pressure (middle panel), and pulse rate (bottom panel). Values are means 1 SD for placebotreated and means 1 SD for estradiol-17 treated women. high BP values. 6 After menopause, the incidence of arterial hypertension progressively increases in women compared with men, becoming prevalent in women compared with age-matched male subjects. 7 In itself, hypertension represents one of the major cardiovascular risk factors 2,7 and hypertensive females are 4 times more likely than age-matched normotensive subjects to develop cardiovascular diseases. 19 In this study, ABPM was performed to examine the diurnal BP variations and to evaluate the effect of physiologic doses of E 2 on the BP profile in women
4 912 MERCURO ET AL AJH AUGUST 1998 VOL. 11, NO. 8, PART 1 TABLE 2. AMBULATORY BLOOD PRESSURE MONITORING IN DIPPER AND NONDIPPER POSTMENOPAUSAL HYPERTENSIVE WOMEN AT BASELINE AND AFTER PLACEBO OR ESTRADIOL-17 Dippers (n 18) Nondippers (n 12) Basal Placebo E 2 Basal Placebo E 2 24-h SBP (mm Hg) * * DBP (mm Hg) * * PR (bpm) * Daytime SBP (mm Hg) * DBP (mm Hg) PR (bpm) * Nighttime SBP (mm Hg) * # * DBP (mm Hg) # 82 3 PR (beats/min) DBP, diastolic blood pressure; SBP, systolic blood pressure; E 2, estradiol-17 ; PR, pulse rate. *P.05, P.01 v respective placebo; P.05 v dippers basal; #P.05 v dippers placebo; P.05 v dippers E 2. with mild hypertension occurring subsequent to menopause. The nondipper subjects were defined as those whose nocturnal decrease of systolic BP was less than 10% of daytime BP. Present results, confirming a previous observation, 11 showed that E 2 is effective in lowering elevated BP levels in women with postmenopausal essential hypertension. Furthermore, estrogen demonstrated beneficial effects in both dipper and nondipper subjects. A decrease in BP during sleep occurs in normal subjects and in patients with uncomplicated essential hypertension. Patients with a flattened diurnal ABP profile are subject to increased risk for target-organ damage. The nondipping pattern may be a sufficient determinant of left ventricular wall thickening 20 and can be associated with hypertensive target-organ damage such as silent stroke, Binswanger s dementia, 21 and faster progression of renal insufficiency in renal hypertensive subjects. 22 A blunted or absent nocturnal fall of ABP has been found to be associated with higher future cardiovascular morbid events among women with ambulatory hypertension, 10,23 even though we did not distinguish between premenopausal and postmenopausal subjects. Slightly less than one-third of all patients with essential hypertension revealed an impaired nocturnal decline of BP. 24,25 Our study demonstrates a greater existence of this phenomenon (about 40%) among postmenopausal women, although the modest number of cases examined requires further confirmation. Estradiol-17, in addition to lowering elevated BP levels and maintaining a uniform BP control over 24 h, was able to restore a physiologic nocturnal fall in nondipper hypertensive postmenopausal women. The present findings seem to suggest a mechanism of increased cardiovascular risk after menopause. A persistent pressure overload, expressed by a blunted nocturnal reduction in BP, might increase the progression of hypertensive organ damage and could be responsible, at least in part, for a higher incidence of cardiovascular events. Larger scale studies are necessary to verify whether ovarian dysfunction is able to promote a flattened BP curve and transform a dipper into a nondipper profile in both normotensive and hypertensive women, with important implications in end-organ damage. Estrogen replacement therapy in menopause protects against osteoporosis and alleviates irritating menopausal symptoms. In the light of the present findings, the hormone treatment might contain a beneficial cardioprotective activity in patients with diurnal BP problems showing signs or symptoms of cessation of the ovarian function. ACKNOWLEDGMENTS We gratefully acknowledge Angela Pisanu and Rita Figus for their technical support and Maria Leo for her excellent graphic assistance. REFERENCES 1. Landahl S, Bengtsson C, Sigurdsson JA, et al: Agerelated changes in blood pressure. Hypertension 1986; 8: Staessen J, Bulpitt CJ, Fagard R, et al: The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: Kotchen JM, McKean HE, Kotchen TA: Blood pressure trends with aging. Hypertension 1982;4(suppl III): Sigurdsson JA: High blood pressure in women. A
5 AJH AUGUST 1998 VOL. 11, NO. 8, PART 1 HYPERTENSION, MENOPAUSE, AND TRANSDERMAL ESTROGEN 913 cross-sectional and a longitudinal follow-up study. Acta Med Scand 1983;669(suppl): Harlan WR, Hull AL, Schmouder RL, et al: Blood pressure and nutrition in adults. The National Health and Nutrition Examination Survey. Am J Epidemiol 1984; 120: Lamy PP: Cardiovascular disease in the elderly. US Pharm 1991;16(suppl): Anastos K, Charney P, Charon RA, et al: Hypertension in women: what is really known? The Women s Caucus, Working Group on Women s Health of the Society of General Internal Medicine. Ann Intern Med 1991; 115: Weiss NS: Relationship of menopause to serum cholesterol and arterial pressure: the United States Health Examination Survey of Adults. Am J Epidemiol 1972; 96: Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study. N Engl J Med 1991;325: Verdecchia P, Schillaci G, Gatteschi C, et al: Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993;88: Mercuro G, Zoncu S, Pilia I, et al: Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol 1997;80: Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153: Staessen JA, Fagard R, Thijs L, et al: A Consensus view on the technique of ambulatory blood pressure monitoring. Hypertension 1995;26(part 1): Giannessi P, Zucchelli GC, Simonini N, et al: Methodological validation of human chorionic somatomammotropin, estriol, estradiol and progesterone radioimmunoassay in pregnancy. J Nucl All Sci 1978;22: Kannel WB, Hjortland MC, McNamara PM, et al: Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85: Colditz GA, Willett WC, Stampfer MJ, et al: Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316: Bush TL, Miller VT: Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins, in Mishell D (eds): Menopause: Physiology and Pharmacology. Year Book Medical, Chicago, 1986, pp Parrish HM, Carr LA, Hall DG: Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol 1967;99: Kitler ME: Differences in men and women in coronary artery disease, systemic hypertension and their treatment. Am J Cardiol 1992;70: Verdecchia P, Schillaci G, Borgioni C, et al: Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers. Am J Hypertens 1995;8: Kuwajima I: Ambulatory blood pressure in the elderly with hypertension. Nippon Ronen Igakkai Zasshi 1994; 31: Timio M, Venanzi S, Lolli S, et al: Non-dipper hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995;43: Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An indipendent predictor of prognosis in essential hypertension. Hypertension 1994;24: Zweiker R, Eber B, Schumacher M, et al: Non-dipping related to cardiovascular events in essential hypertensive patients. Acta Med Austriaca 1994;21: Muna W, Kingue S, Kim KS, et al: Circadian rhythm of hypertensives in a Cameroon population: a pilot study. J Hum Hypertens 1995;9:
ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*
Progress in Clinical Medicine 1 ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION* Keishi ABE** Asian Med. J. 44(2): 83 90, 2001 Abstract: J-MUBA was a large-scale clinical
More informationTime of day for exercise on blood pressure reduction in dipping and nondipping hypertension
(2005) 19, 597 605 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE on blood pressure reduction in dipping and nondipping hypertension S Park,
More informationChapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women
Blood pressure and heart rate variability as function of ovarian cycle in young women INTRODUCTION In human females, the menstrual cycle begins with the onset of menstrual flow on day 1. The menstrual
More informationBRIEF COMMUNICATIONS. KEY WORDS: Ambulatory blood pressure monitoring, placebo effect, antihypertensive drug trials.
AJH 1995; 8:311-315 BRIEF COMMUNICATIONS Lack of Placebo Effect on Ambulatory Blood Pressure Giuseppe Mancia, Stefano Omboni, Gianfranco Parati, Antonella Ravogli, Alessandra Villani, and Alberto Zanchetti
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationPrognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
(2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and
More informationChapter-V. Summary, Conclusions and Recommendations
Summary, Conclusions and Recommendations INTRODUCTION The work included in this thesis entitled, Circadian heart rate and blood pressure variability in apparently healthy subjects using ABPM has been divided
More informationPremenopausal women have a lower cardiovascular
AJH 1998;11:1147 1152 Ambulatory Not Office Blood Pressures Decline During Hormone Replacement Therapy in Healthy Postmenopausal Women Frans J. van Ittersum, W. Marchien van Baal, Peter Kenemans, Velja
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationDIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING
DIURNAL VARIATIONS IN BLOOD PRESSURE AND THEIR RELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKENING Sh Narooei (1), B Soroor (2), F Zaker (3) Abstract INTRODUCTION: Hypertension is a very common cardiovascular
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationComparison of arbitrary definitions of circadian time periods with those determined by wrist actigraphy in analysis of ABPM data
Journal of Human Hypertension (1999) 13, 449 453 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Comparison of arbitrary definitions of
More informationAGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston
AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences
More informationInsulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationAn Observational Study: Ambulatory Blood Pressure Monitoring after Percutaneous Transluminal Coronary Angioplasty
THIEME Original Article 17 An Observational Study: Ambulatory Blood Pressure Monitoring after Percutaneous Transluminal Coronary Angioplasty Gopi Krishna Kenchi 1 Sunisha Gajula 2 Malleshwar Rao Dangati
More informationAJH 1999;12: Downloaded from by guest on 15 December 2018
AJH 1999;12:806 814 Differential Effects of Morning and Evening Dosing of Nisoldipine ER on Circadian Blood Pressure and Heart Rate William B. White, George A. Mansoor, Thomas G. Pickering, Donald G. Vidt,
More informationAmbulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease. Rajiv Agarwal, MD
Ambulatory Blood Pressure and Cardiovascular Events in Chronic Kidney Disease Rajiv Agarwal, MD Summary: Hypertension is an important risk factor for adverse cardiovascular and renal outcomes, particularly
More informationAbody of evidence demonstrates that alcohol
BRIEF COMMUNICATIONS AJH 1998;11:230 234 The Effects of Alcohol Consumption on Ambulatory Blood Pressure and Target Organs in Subjects With Borderline to Mild Hypertension Olga Vriz, Diana Piccolo, Enrico
More informationThe incidence of transient myocardial ischemia,
AJH 1999;12:50S 55S Heart Rate and the Rate-Pressure Product as Determinants of Cardiovascular Risk in Patients With Hypertension William B. White Inability to supply oxygen to the myocardium when demand
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationNight time blood pressure and cardiovascular structure in a middle-aged general population in northern Italy: the Vobarno Study
(2001) 15, 879 885 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Night time blood pressure and cardiovascular structure in a middle-aged general
More informationHow well do office and exercise blood pressures predict sustained hypertension? A Dundee Step Test Study
(2000) 14, 429 433 2000 Macmillan Publishers Ltd All rights reserved 0950-9240/00 $15.00 www.nature.com/jhh ORIGINAL ARTICLE How well do office and exercise blood pressures predict sustained hypertension?
More informationEvaluation of the Extent and Duration of the ABPM Effect in Hypertensive Patients
Journal of the American College of Cardiology Vol. 40, No. 4, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02011-9
More informationAmbulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair
Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right Anthony J. Viera, MD, MPH, FAHA Professor and Chair Objectives Review limitations of office BP in making a correct diagnosis of hypertension
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationAmbulatory Blood Pressure Monitoring Clinical Practice Recommendations
Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationSUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
More informationa Hypertension and Cardiovascular Rehabilitation Unit, Faculty of Medicine, Received 2 June 2008 Revised 1 July 2008 Accepted 9 July 2008
Original article 325 Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease Robert H. Fagard a, Lutgarde Thijs a, Jan A. Staessen a, Denis
More informationArterial blood pressure (BP) follows a circadian
Original Paper Relationship Between Exercise Heart Rate Recovery and Circadian Blood Pressure Pattern Sercan Okutucu, MD; Giray Kabakci, MD; Onur Sinan Deveci, MD; Hakan Aksoy, MD; Ergun Baris Kaya, MD;
More informationEchocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?
Journal of Human Hypertension (1999) 13, 505 509 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Echocardiographic definition of left ventricular
More informationNocturnal Blood Pressure in Treated Hypertensive African Americans Compared to Treated Hypertensive European Americans1
Nocturnal Blood Pressure in Treated Hypertensive African Americans Compared to Treated Hypertensive European Americans1 Lee A. Hebert,2 Garima Agarwal, Stephanie E. Ladson-Wofford, Max Reif, Leena Hiremath,
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationEffects of exercise, diet and their combination on blood pressure
(2005) 19, S20 S24 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effects of exercise, diet and their combination on blood pressure Department
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationSTATE OF THE ART BP ASSESSMENT
STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationJournal of Hypertension 2004, 22: a Hypertension and Cardiovascular Rehabilitation Unit, Catholic University of
Original article 81 Relationship between ambulatory blood pressure and followup clinic blood pressure in elderly patients with systolic hypertension Robert H. Fagard a, Jan A. Staessen a, Lutgarde Thijs
More informationHigh-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension
(2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers
More informationIncidental Findings; Management of patients presenting with high BP. Phil Swales
Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental
More informationMetoprolol Succinate SelokenZOC
Metoprolol Succinate SelokenZOC Blood Pressure Control and Far Beyond Mohamed Abdel Ghany World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2014. 1 Death Rates From Ischemic
More informationNormal Ambulatory Blood Pressure: A Clinical-Practice- Based Analysis of Recent American Heart Association Recommendations
The American Journal of Medicine (2006) 119, 69.e13-69.e18 CLINICAL RESEARCH STUDY Normal Ambulatory Blood Pressure: A Clinical-Practice- Based Analysis of Recent American Heart Association Recommendations
More informationComparison of 44-Hour and Fixed 24-Hour Ambulatory Blood Pressure Monitoring in Dialysis Patients
ORIGINAL PAPER Comparison of 44-Hour and Fixed 24-Hour Ambulatory Blood Pressure Monitoring in Dialysis Patients Wenjin Liu, MD; Hong Ye, MD; Bing Tang, MD; Zhiping Sun, MD; Ping Wen, MD; Wenhui Wu, MD;
More informationPrognostic significance of blood pressure measured on rising
(2001) 15, 413 417 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured on rising P Gosse, C Cipriano,
More informationWomen and Heart Disease
Women and Heart Disease The Very Latest in Cardiovascular Medicine and Surgery Gretchen L. Wells, MD, PhD, FACC Thomas Whayne Endowed Professor in Women s Heart Health Gill Heart Institute University of
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationRisk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication
41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationWhite coat and masked hypertension
White coat and masked hypertension Conflict of interest Support from Spacelabs, Microlife. Honoraria from Novartis, Elpen, Boeringer-Ingelheim, CANA, Lilly, MSD, Sanofi, Menarini, Ciezi, Astra-Zeneca.
More informationBlood Pressure Monitoring in Chronic Kidney Disease
Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American
More informationMasked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology
Masked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology Giovanni Di Salvo MD, PhD, MMSc, FESC BACKGROUND MASKED HYPERTENSION Masked hypertension (MH) consists of an elevated
More informationAssessing Blood Pressure for Clinical Research: Pearls & Pitfalls
Assessing Blood Pressure for Clinical Research: Pearls & Pitfalls Anthony J. Viera, MD, MPH, FAHA Department of Family Medicine Hypertension Research Program UNC School of Medicine Objectives Review limitations
More informationTherapeutic Cohort Results
Patient: SAMPLE PATIENT DOB: Sex: MRN: Menopause Plus - Salivary Profile Therapeutic Cohort Results Hormone Average Result QUINTILE DISTRIBUTION 1st 2nd 3rd 4th 5th Therapeutic Range* Estradiol (E2) 8.7
More informationHow do we diagnose hypertension today? Presentation Subtitle
How do we diagnose hypertension today? Presentation Subtitle Renata Cífková Case 1 JM, a 64-year-old lady referred to our center because of undesirable effects of her antihypertensive medication Personal
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationThe hypertensive effects of the renin-angiotensin
Comparison of Telmisartan vs. Valsartan in the Treatment of Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring George Bakris, MD A prospective, randomized, open-label, blinded end-point
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationLow & Ultra Low Dose HRT The Cardiovascular Impact
Low & Ultra Low Dose HRT The Cardiovascular Impact Wyeth Symposium, Turin 29 th Sept 2007 Nick Panay Consultant Gynaecologist Queen Charlotte s & Chelsea and Chelsea & Westminster Hospitals Honorary Senior
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationBlood pressure (BP) in healthy people follows a circadian
The Effect of Measuring Ambulatory Blood Pressure on Nighttime Sleep and Daytime Activity Implications for Dipping Rajiv Agarwal and Robert P. Light Indiana University School of Medicine and Richard L.
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationDoes the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
(24) 18, S23 S28 & 24 Nature Publishing Group All rights reserved 95-92/4 $3. www.nature.com/jhh ORIGINAL ARTICLE Does the reduction in systolic blood pressure alone explain the regression of left ventricular
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationESSENTIAL hypertension is a major risk factor for coronary artery disease,
The Frequency of Combined Target Organ Damage and the Beneficial Effect of Ambulatory Blood Pressure Monitoring in Never Treated Mild-to-Moderate Hypertensive Patients Dilek TORUN, 1 MD, Siren SEZER, 2
More informationEarly Detection of Damaged Organ
Early Detection of Damaged Organ Regional Cardiovascular Center, Chungbuk National University Kyung-Kuk Hwang Contents NICE guideline 2011 - Confirm the diagnosis of HT ambulatory blood pressure monitoring
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More information24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting
2017 Dementia 24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting Wat gebruiken in de klinische praktijk? Jan A. Staessen, MD, PhD KU Leuven jan.staessen@kuleuven.be BPM Key messages to be made
More informationHypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town
Hypertension targets: sorting out the confusion Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Historical Perspective The most famous casualty of this approach was the
More informationAmbulatory blood pressure (ABP) may be normal in
Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension Robert H. Fagard, MD; Jan A. Staessen, MD; Lutgarde Thijs, BSc; Jerzy Gasowski, MD; Christopher
More informationΗ σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις
Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις Ελένη Τριανταφυλλίδη Επιμελήτρια Α Β Πανεπιστημιακή Καρδιολογική Κλινική Αττικό Νοσοκομείο
More informationJournal of the American College of Cardiology Vol. 38, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01348-1 Blood
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationUpdate on CVD and Microvascular Complications in T2D
Update on CVD and Microvascular Complications in T2D Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine
More informationAmerican Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease
American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease AMWA is a leader in its dedication to educating all physicians and their patients about heart disease,
More informationTherapeutic Cohort Results
Patient: PAGE LOVE DOB: January 11, 1983 Sex: F MRN: 1232704193 Order Number: J9020008 Completed: July 08, 2016 Received: July 02, 2016 Collected: July 01, 2016 Aum Healing Center Sarika Arora MD 332 Newbury
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationThe Relationship Between Ambulatory Arterial Stiffness Index and Blood Pressure Variability in Hypertensive Patients
ORIGINAL ARTICLE DOI 10.4070/kcj.2011.41.5.235 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright 2011 The Korean Society of Cardiology Open Access The Relationship Between Ambulatory Arterial Stiffness
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationMany observational studies evaluating the changing pattern
Effect of Aging on the Prognostic Significance of Ambulatory Systolic, Diastolic, and Pulse Pressure in Essential Hypertension Rajdeep S. Khattar, BM, MRCP; John D. Swales, MA, MD, FRCP; Caroline Dore,
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationANNALS of Internal Medicine
ANNALS of Internal Medicine AUGUST 1978 VOLUME 89 NUMBER 2 Published Monthly by the American College of Physicians Menopause and Coronary Heart Disease The Framingham Study TAVIA GORDON; WILLIAM B. KANNEL,
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationEffects of the Transition from Premenopause to Postmenopause on Lipids and Lipoproteins: Quantification and Related Parameters
ORIGINAL ARTICLE DOI: 10.3904/kjim.2011.26.1.47 Effects of the Transition from Premenopause to Postmenopause on Lipids and Lipoproteins: Quantification and Related Parameters Eun Jeung Cho 1, Yun Joo Min
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationNighttime Blood Pressure Fall in Renal Disease Patients
Renal Failure ISSN: 0886-022X (Print) 1525-6049 (Online) Journal homepage: http://www.tandfonline.com/loi/irnf20 Nighttime Blood Pressure Fall in Renal Disease Patients Dr. Nicolás Roberto Robles, Barbara
More informationBLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN?
BLOOD PRESSURE MEASUREMENT HOME BASED OR OFFICE BP MONITORING WHICH, HOW AND WHEN? DECLARATION OF INTEREST Medical Director and Chairman, Advisory Board dabl Ltd., Dublin, Ireland. BLOOD PRESSURE MEASUREMENT
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More information